SILLAJEN BIOTHERAPEUTICS, INC.
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 130 Total Citation Count
- Sep 07, 2006 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0037,355 GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUSJan 04, 12Feb 05, 15[A61K, C12N, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9919047 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusJan 04, 12Mar 20, 18[A61K, C12N, G01N, C07K]
9827278 Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxvirusesOct 06, 15Nov 28, 17[A61K, C12N, A01K, C07K]
9180149 Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxvirusesSep 07, 06Nov 10, 15[A61K, C12N, A01K, C07K]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.